<DOC>
	<DOCNO>NCT02140801</DOCNO>
	<brief_summary>A number 352 patient schedule elective percutaneous coronary intervention ( PCI ) native coronary stenosis suitable DES implantation OCT image openly randomize 1:1 either BRILINTA™ ( ticagrelor ) Plavix® ( clopidogrel bisulfate ) .</brief_summary>
	<brief_title>Optical Coherence Tomography Evaluate Ticagrelor Clopidogrel</brief_title>
	<detailed_description>The study prospectively conduct 4 high-volume PCI center China OCT expertise . Angiographic follow-up OCT image motorize pull-back 1 mm/s plan patient 12 month implantation study stent . OCT endpoint : ( 1 ) Subclinical intra-stent thrombus , define mass protrude lumen significant attenuation , respectively ( 2 ) endothelial coverage , express % strut without coverage % stent length contain non-covered strut . The study power OCT endpoint , likely reach significance level P &lt; 0.05 even follow-up drop-out rate 10 % .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Provision inform consent prior study specific procedure ; Men woman 18 year old ; . Established indication PCI accord guideline American Heart Association American College Cardiology ; Native coronary lesion suitable drugeluting stent placement OCT imaging . Pregnancy breast feed mother ; Comorbidity estimate life expectancy &lt; 50 % 12 month ; Scheduled major surgery next 6 month ; Inability follow protocol comply followup requirement reason investigator feel would place patient increase risk ; Previous enrolment study treatment investigational drug device another study protocol past 30 day Cardiogenic shock Previous subacute late coronary stent thrombosis Known allergy ticagrelor , clopidogrel , aspirin History major hemorrhage ( intracranial , gastrointestinal , etc . ) Active pathological bleeding Acute chronic hematologic disorder include Hemoglobin le 10 g/L platelet count le 10×109/L procedure Any history Severe renal hepatic dysfunction ( hepatic failure , cirrhosis , portal hypertension active hepatitis ) ; Neutropenia , thrombocytopenia ; Known acute pancreatitis Arterial aneurysm , arterial/venous malformation aorta dissection . Culprit lesion within proximal 10 mm right leave coronary artery Saphenous vein graft Lesion length &gt; 30 mm Involves side branch ≥2.0 mm diameter visual estimate require treatment Instent restenotic lesion Thombuscontaining lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Thrombosis</keyword>
</DOC>